DaVita Inc. (DVA) Q4 FY25 Earnings Call

IKC profitability and capital allocation support earnings growth, but dialysis volume remains constrained by mortality and insurance headwinds.

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2026-02-03
Length44 minutes
EPS$3.40
EPS consensus$3.24
Revenue$3.6B

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

All DVA earnings ยท Back to DVA overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.